As of March 9, 2021, India has secured some 2.2 billion COVID-19 vaccine doses through contracts in total. India chose to purchase vaccines manufactured by AstraZeneca (Oxford), Novavax, and the Russian Gamaleya Institute. However, the overwhelming majority of these doses have yet to be produced and delivered. This statistic shows the size of COVID-19 vaccine contracts based on number of doses secured by countries through contracts with manufacturers. The AstraZeneca/Oxford vaccine is by far the most sought COVID-19 vaccine, especially due to its ability to be stored at normal refrigerator temperatures, while other vaccines need ultra cold storage.
Size of COVID-19 vaccine contracts between countries and manufacturers as of March 2021
(in million doses)
This is a selection of the most prominent vaccines (already approved or on track to be approved) and some countries/regions.
When country contracts include a range of doses to be purchased, we count the lower number. On Dec. 23, Canada’s contracts were updated to reflect those details verified by the government.The Latin America bloc covers all countries in the region except Brazil. The European Union bloc represents the 27 countries of the European Union. The Covax agreement extends to most countries in the world, including many in Africa that wouldn’t otherwise be covered. Jurisdictions without a population figure, such as Somalia and Syria, have been omitted. The Middle East bloc covers U.A.E., Egypt, Bahrain and Jordan. Partnerships involving local manufacturers are listed under the original vaccine developer.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Bloomberg. (March 9, 2021). Size of COVID-19 vaccine contracts between countries and manufacturers as of March 2021 (in million doses) [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/1195885/covid-19-vaccines-by-contract-size/
Bloomberg. "Size of COVID-19 vaccine contracts between countries and manufacturers as of March 2021 (in million doses)." Chart. March 9, 2021. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/1195885/covid-19-vaccines-by-contract-size/
Bloomberg. (2021). Size of COVID-19 vaccine contracts between countries and manufacturers as of March 2021 (in million doses). Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/1195885/covid-19-vaccines-by-contract-size/
Bloomberg. "Size of Covid-19 Vaccine Contracts between Countries and Manufacturers as of March 2021 (in Million Doses)." Statista, Statista Inc., 9 Mar 2021, https://www.statista.com/statistics/1195885/covid-19-vaccines-by-contract-size/
Bloomberg, Size of COVID-19 vaccine contracts between countries and manufacturers as of March 2021 (in million doses) Statista, https://www.statista.com/statistics/1195885/covid-19-vaccines-by-contract-size/ (last visited November 21, 2024)
Size of COVID-19 vaccine contracts between countries and manufacturers as of March 2021 (in million doses) [Graph], Bloomberg, March 9, 2021. [Online]. Available: https://www.statista.com/statistics/1195885/covid-19-vaccines-by-contract-size/
